End of this page section.
Go to overview of page sections.
Begin of page section: Additional information:
End of this page section.
Go to overview of page sections.
INTERACD+
Begin of page section: Contents:
The INTERACD+ consortium will study the preventive potential of nicotinamide adenine dinucleotide (NAD+) replenishment combined with exercise on obesity-related cardiometabolic syndrome. We aim to (1) uncover NAD+ and exercise-driven metabolic outcomes and mechanisms in a preclinical rat model of cardiometabolic syndrome, (2) analyze an existing prospective human cohort at cardiometabolic risk, and (3) perform a first-in-human pilot feasibility trial by combining an NAD precursor supplementation with exercise in patients at cardiometabolic risk.
End of this page section.
Go to overview of page sections.
Cooperating partners
Begin of page section:
BioTechMed-Graz Coordination Office
Mozartgasse 12/II
8010 Graz
Christina Prix
Margit List-Schleich
Julia Rohrer
End of this page section.
Go to overview of page sections.
